Skip to main content
. 2024 May 31;16(11):2101. doi: 10.3390/cancers16112101

Figure 1.

Figure 1

Chemoresistance in pancreatic ductal adenocarcinoma. Increased pro-inflammatory cytokines, extracellular matrix remodeling of the stroma, epithelial–mesenchymal transition, and mutations contribute to chemoresistance in pancreatic ductal adenocarcinoma. Interleukin (IL), cluster of differentiation (CD), insulin-like growth factor (IGF), and pancreatic stellate cells (PSCs).